Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
MoonLake Immunotherapeutics | Director | Class A ordinary shares, par value $0.0001 per share | 172K | $9.24M | $53.72 | Oct 4, 2024 | Direct |
MoonLake Immunotherapeutics | Director | Option to Buy | 7.69K | Jun 6, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MLTX | MoonLake Immunotherapeutics | Oct 4, 2024 | 1 | -$9.19M | 4 | Oct 8, 2024 | Director |
MLTX | MoonLake Immunotherapeutics | Jun 6, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
MLTX | MoonLake Immunotherapeutics | Oct 1, 2023 | 3 | $0 | 4 | Oct 3, 2023 | Director |
MLTX | MoonLake Immunotherapeutics | Jun 8, 2023 | 1 | $0 | 4 | Jun 12, 2023 | Director |
MLTX | MoonLake Immunotherapeutics | Apr 6, 2022 | 1 | $0 | 4 | May 5, 2022 | Director |
MLTX | MoonLake Immunotherapeutics | Apr 5, 2022 | 0 | $0 | 3 | Apr 15, 2022 | Director |